Bioinformatics Market Size, Share, and Growth Analysis, By Product (Knowledge Management Tools, Bioinformatics Platforms), By Application (Genomics, Chemoinformatics & Drug Design), By Sector, By Region - Industry Forecast 2025-2032
바이오인포매틱스 세계 시장 규모는 2023년 116억 달러, 2024년 131억 7,000만 달러에서 2032년 362억 6,000만 달러로 성장할 것으로 예상되며, 예측 기간(2025-2032년) 동안 13.5%의 연평균 복합 성장률(CAGR)을 보일 것으로 예측됩니다.
RasMol, AUTODOCK, Bioclipse와 같은 사용자 친화적인 바이오인포매틱스 소프트웨어는 데이터 접근성 및 분석을 강화하여 R&D 이니셔티브에 필수적인 역할을 하고 있습니다. 데이터 접근성 및 분석을 강화하여 R&D 이니셔티브에 필수적인 요소로 자리 잡고 있습니다. 다양한 '-omics' 분야의 연구 프로그램이 확대됨에 따라 정교한 데이터 저장 및 분석 솔루션에 대한 수요는 증가하는 추세입니다. 특히, 스탠포드 의대에서 보고한 바와 같이 DNA 염기서열 분석 기술의 발전으로 인간 유전체을 약 8시간 만에 해독할 수 있게 되면서 유전체 분석에 대한 수요가 더욱 증가하고 있습니다. 이러한 급증은 유전성 질환, 화학적 예방, 발암물질 연구와 관련된 복잡한 과제를 해결하는 데 있어 바이오인포매틱스의 중요성을 강조하며, 이 분야가 현대 의학에서 중요한 역할을 담당하고 있음을 강조하고 있습니다.
목차
서론
조사 방법
- 정보 조달
- 2차와 1차 데이터 방법
- 시장 규모 예측
- 시장 전제조건과 제한
주요 요약
- 세계 시장 전망
- 공급과 수요 동향 분석
- 부문별 기회 분석
시장 역학과 전망
- 시장 개요
- 시장 규모
- 시장 역학
- Porter의 Five Forces 분석
주요 시장 인사이트
- 중요 성공 요인
- 경쟁 정도
- 주요 투자 기회
- 시장 생태계
- 시장의 매력 지수(2024년)
- PESTEL 분석
- 거시경제 지표
- 밸류체인 분석
- 규제 분석
- 기술 분석
- 사례 연구
바이오인포매틱스 시장 규모 : 제품 및 서비스별
- 시장 개요
- 지식 관리 툴
- 바이오인포매틱스 플랫폼
- 데이터 분석 플랫폼
- 구조 및 기능 분석 플랫폼
- 기타 바이오인포매틱스 플랫폼
- 바이오인포매틱스 서비스
- 시퀀싱 서비스
- 데이터 분석 서비스
- Drug Discovery 서비스
- 유전자 발현차이 분석 서비스
- 데이터베이스 및 관리 서비스
- 기타 바이오인포매틱스 서비스
바이오인포매틱스 시장 규모 : 용도별
- 시장 개요
- 유전체학
- 화학정보학 및 의약품 설계
- 단백질체학
- 전사체학
- 대사체학
- 기타 용도
바이오인포매틱스 시장 규모 : 분야별
- 시장 개요
- 의료 바이오기술
- Drug Discovery & Development
- 임상 진단 및 맞춤형 의료
- 생식 보건
- 동물 바이오기술
- 식물 바이오기술
- 환경 바이오기술
- 법의학 바이오기술
- 기타 부문
바이오인포매틱스 시장 규모
- 북미
- 유럽
- 아시아태평양
- 라틴아메리카
- 중동 및 아프리카
- GCC 국가
- 남아프리카공화국
- 기타 중동 및 아프리카
경쟁 정보
- 주요 5개사 비교
- 주요 기업의 시장 포지셔닝(2024년)
- 주요 시장 기업이 채택한 전략
- 최근 시장 동향
- 기업의 시장 점유율 분석(2024년)
- 주요 기업 개요
- 기업 상세
- 제품 포트폴리오 분석
- 기업 부문별 점유율 분석
- 매출 전년대비 비교(2022-2024년)
주요 기업 개요
- Illumina Inc.(US)
- Thermo Fisher Scientific Inc.(US)
- Qiagen N.V.(Netherlands)
- Agilent Technologies Inc.(US)
- BGI Group(China)
- PerkinElmer Inc.(US)
- Eurofins Scientific SE(Europe)
- Waters Corporation(US)
- DNAnexus Inc.(US)
- Sophia Genetics SA(Switzerland)
- Partek Incorporated(US)
- Gene Codes Corporation(US)
- Dassault Systemes SE(France)
- Biomax Informatics AG(Germany)
- Bruker Corporation(US)
- Macrogen Inc.(South Korea)
결론과 제안
LSH
Global Bioinformatics Market size was valued at USD 11.6 billion in 2023 and is poised to grow from USD 13.17 billion in 2024 to USD 36.26 billion by 2032, growing at a CAGR of 13.5% during the forecast period (2025-2032).
The bioinformatics market is poised for significant growth during the forecast period, primarily driven by escalating private and public investments in drug research and development. User-friendly bioinformatics software such as RasMol, AUTODOCK, and Bioclipse enhance data accessibility and analysis, making them integral to R&D initiatives. As research programs expand across various '-omics' fields, the demand for sophisticated data storage and analytical solutions is set to increase. Notably, advancements in DNA sequencing technologies, like those reported by Stanford Medicine, can now decode the human genome in about eight hours, further propelling the demand for genomic analysis. This surge emphasizes the importance of bioinformatics in addressing complex challenges related to genetic diseases, chemoprevention, and carcinogen research, underscoring the sector's critical role in modern healthcare.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Bioinformatics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Bioinformatics Market Segments Analysis
Global Bioinformatics Market is segmented by Product, Application, Sector and region. Based on Product, the market is segmented into Knowledge Management Tools, Bioinformatics Platforms and Bioinformatics Services. Based on Application, the market is segmented into Genomics, Chemoinformatics & Drug Design, Proteomics, Transcriptomics, Metabolomics and Other Applications. Based on Sector, the market is segmented into Medical Biotechnology, Animal Biotechnology, Plant Biotechnology, Environmental Biotechnology, Forensic Biotechnology and Other Sectors. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Bioinformatics Market
The expansion of personalized medicine is a significant catalyst for the global bioinformatics market. As healthcare shifts toward tailored treatment approaches grounded in individual genetic profiles, there is a rising necessity for bioinformatics tools designed to process and analyze extensive genetic datasets. This escalating demand is propelling the utilization of bioinformatics across pharmaceutical sectors, enhancing diagnostics, evaluation processes, and treatment alternatives. Consequently, the integration of advanced bioinformatics solutions is becoming essential to leverage genetic insights effectively, ultimately fostering more precise and personalized healthcare outcomes. This trend highlights the pivotal role bioinformatics plays in the future of medicine.
Restraints in the Global Bioinformatics Market
The Global Bioinformatics market faces significant challenges due to the high expenses linked to software, hardware, and services. The substantial investment required for bioinformatics systems can pose a financial burden, particularly for smaller research institutions and companies, especially in developing regions with limited market expansion potential. These costs can act as a barrier to entry, inhibiting the adoption of innovative bioinformatics solutions and restricting the overall growth of the market. Consequently, organizations may struggle to access the necessary tools and technologies that facilitate advancements in research and development within the biosciences sector.
Market Trends of the Global Bioinformatics Market
The Global Bioinformatics market is increasingly driven by the integration of artificial intelligence (AI) and machine learning (ML), positioning these technologies as vital components of bioinformatics solutions. These AI-powered tools enhance data analysis capabilities, allowing for expedited and precise interpretation of complex biological datasets. The trend signifies a shift towards improved predictive modeling, more refined pattern recognition, and sophisticated decision-making strategies across various applications, including drug discovery, genomics, and personalized medicine. As the demand for faster and more reliable insights into biological phenomena grows, the bioinformatics sector is poised for robust growth, fostering innovation and collaboration within the life sciences industry.
Table of Contents
Introduction
- Objectives of the Study
- Scope of the Report
- Definitions
Research Methodology
- Information Procurement
- Secondary & Primary Data Methods
- Market Size Estimation
- Market Assumptions & Limitations
Executive Summary
- Global Market Outlook
- Supply & Demand Trend Analysis
- Segmental Opportunity Analysis
Market Dynamics & Outlook
- Market Overview
- Market Size
- Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
- Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers
Key Market Insights
- Key Success Factors
- Degree of Competition
- Top Investment Pockets
- Market Ecosystem
- Market Attractiveness Index, 2024
- PESTEL Analysis
- Macro-Economic Indicators
- Value Chain Analysis
- Regulatory Analysis
- Technology Analysis
- Case Studies
Global Bioinformatics Market Size by Product & Service & CAGR (2025-2032)
- Market Overview
- Knowledge Management Tools
- Generalized Knowledge Management Tools
- Specialized Knowledge Management Tools
- Bioinformatics Platforms
- Data Analysis Platforms
- Structural & Functional Analysis Platforms
- Other Bioinformatics Platforms
- Bioinformatics Services
- Sequencing Services
- Data Analysis Services
- Drug Discovery Services
- Differential Gene Expression Analysis Services
- Database And Management Services
- Other Bioinformatics Services
Global Bioinformatics Market Size by Application & CAGR (2025-2032)
- Market Overview
- Genomics
- Chemoinformatics & Drug Design
- Proteomics
- Transcriptomics
- Metabolomics
- Other Applications
Global Bioinformatics Market Size by Sector & CAGR (2025-2032)
- Market Overview
- Medical Biotechnology
- Drug Discovery & Development
- Clinical Diagnostics & Personalized Medicine
- Reproductive Health
- Animal Biotechnology
- Plant Biotechnology
- Environmental Biotechnology
- Forensic Biotechnology
- Other Sectors
Global Bioinformatics Market Size & CAGR (2025-2032)
- North America (Product & Service, Application, Sector)
- Europe (Product & Service, Application, Sector)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Product & Service, Application, Sector)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Product & Service, Application, Sector)
- Brazil
- Rest of Latin America
- Middle East & Africa (Product & Service, Application, Sector)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2024
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2024
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)
Key Company Profiles
- Illumina Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Qiagen N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Agilent Technologies Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BGI Group (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- PerkinElmer Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Eurofins Scientific SE (Europe)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Waters Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- DNAnexus Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sophia Genetics SA (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Partek Incorporated (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Gene Codes Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Dassault Systemes SE (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Biomax Informatics AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bruker Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Macrogen Inc. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Conclusion & Recommendations
